Kaiting Yang

发表

Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework

P. L. La Riviere, R. Weichselbaum, M. Spiotto, 2022, Nature Biomedical Engineering.

RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

R. Weichselbaum, Yuzhu Hou, M. Beckett, 2020, Cancer Research.

Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse

Ya-jun Guo, yang-xin fu, Xuanming Yang, 2016, Science Translational Medicine.

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling

R. Weichselbaum, E. Chang, yang-xin fu, 2020, The Journal of experimental medicine.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Scientific Reports.

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Journal of Virology.

Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy

R. Weichselbaum, Ziwan Xu, Taokun Luo, 2022, Advanced science.

Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration

R. Weichselbaum, Yangbo Fu, Ziwan Xu, 2022, Nature nanotechnology.

Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade

R. Weichselbaum, Xin Zhao, Kaiting Yang, 2021, Gut.

All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages

R. Weichselbaum, Yuzhu Hou, E. Vokes, 2021, Science Immunology.

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

yang-xin fu, Mingzhao Zhu, Kaiting Yang, 2018, Cell reports.

Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation

J. Gilbert, R. Weichselbaum, Yuzhu Hou, 2021, The Journal of experimental medicine.

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control

Zhichen Sun, yang-xin fu, Jiyun Shi, 2019, Nature Communications.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Scientific Reports.

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

Zhichen Sun, yang-xin fu, Kaiting Yang, 2017, Cancer Immunology Research.

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication

yang-xin fu, Kaiting Yang, J. Wroblewska, 2015, Scientific Reports.

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy.

R. Weichselbaum, Chuan He, C. Luo, 2023, Cancer cell.

RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy.

S. Pitroda, Kaiting Yang, Liangliang Wang, 2023, Med.

Radiotherapy and immunology

S. Pitroda, Kaiting Yang, Liangliang Wang, 2024, The Journal of experimental medicine.

Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy.

Kaiting Yang, Wenbin Lin, Xiaomin Jiang, 2024, ACS nano.

STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition

Taokun Luo, Kaiting Yang, Wenbin Lin, 2024, Science advances.

Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance

A. Arina, S. Pitroda, S. Chmura, 2023, The Journal of clinical investigation.